, /PRNewswire/ -- Guided by WACKER's global leadership, the biotech facility has been at the forefront of cyclodextrin production since it was first built. The cyclodextrin products manufactured by WACKER became known worldwide under the trade names CAVASOL and CAVAMAX . , president of WACKER BIOSOLUTIONS, WACKER's life sciences division, said: " plays a central role within our global network of Biotech and Biopharma sites.
From we supply all our global cyclodextrin customers. It is an important pillar of the BIOSOLUTIONS portfolio and our growth strategy. Our goal is to reach in sales by the year 2030.
This site is essential to help us accomplish this ambition." In recognition of the 25 anniversary of WACKER's production facility in Governor , and Iowa Lt. Governor , extended their well-wishes: "We congratulate WACKER on 25 years of business in .
We thank the corporation for their dedication in manufacturing cyclodextrin for Iowans and those across the global market. We honor this business and its contribution to the community." "WACKER is a valuable member of our innovative industry and the local communities in which it operates," said , President & CEO, American Chemistry Council.
"This milestone is also a celebration of our industry's signature performance initiative under Responsible Care, demonstrating WACKER's commitment to safeguarding human and environmental health as it develops solutions to improve quality of life around the globe." Cyclodextrins are naturally occu.